Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schenley Industries was a prominent American corporation that, while primarily known for its spirits and distilling business, played a vital role in the pharmaceutical industry during the mid-20th century. Through its subsidiary, Schenley Laboratories, the company became a pioneer in the mass production of penicillin, utilizing its industrial-scale fermentation expertise to support the Allied war effort during World War II. Following the war, the company expanded its pharmaceutical operations to include other antibiotics such as streptomycin and developed blood plasma expanders like polyvinylpyrrolidone. In 1960, Schenley sold its pharmaceutical division to the Rexall Drug and Chemical Company to focus on its core beverage business. The company is historically significant in the life sciences for helping transform antibiotic production from small-scale laboratory processes to global industrial manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schenley Industries.